长非编码RNANAV2-AS2通过通过与NAV2mRNA的感觉-反感觉杂交形成来调节EndMT,从而防止动脉样硬化
Guoqing Liu1, Lin Zhu1, Huiying Cai1
1School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250000, Shandong, China; School of Pharmacy, Jining Medical University, Rizhao 276800, Shandong, China.
International journal of biological macromolecules
|July 18, 2025
概括
长非编码RNANAV2-AS2通过防止内皮细胞转化为介质细胞转化 (EndMT) 来抑制动脉样硬化. 过度表达NAV2-AS2减少了小鼠的动脉样硬化,突出了其对心血管疾病的治疗潜力.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 在RNA生物学,RNA生物学.
背景情况:
- 动脉样硬化是心血管疾病的主要原因之一.
- 长非编码RNAs (lncRNAs) 与动脉样硬化病变发生有关.
- 内皮转介质转换 (EndMT) 有助于动脉样硬化斑块的发展.
研究的目的:
- 为了识别涉及动脉样硬化的新 lncRNAs.
- 研究 lncRNA NAV2-AS2 在动脉样硬化和EndMT中的作用.
- 阐明NAV2-AS2在调节EndMT中的分子机制.
主要方法:
- 微阵列分析以确定与动脉样硬化相关的 lncRNAs.
- 在人血清,小鼠模型和细胞培养中进行表达分析.
- 在活体研究中,在ApoE-/-小鼠中使用腺相关病毒 (AAV) 介导的基因传递.
- 涉及RNA双重形成的机制研究,mRNA稳定性测试和蛋白质-蛋白质相互作用分析.
主要成果:
- 在动脉样硬化患者,小鼠模型和牛-LDL刺激细胞中,NAV2-AS2表达减少.
- 在内皮细胞中NAV2-AS2的过度表达在ApoE-/-小鼠中预防和治疗了饮食诱导的动脉样硬化.
- NAV2-AS2通过与NAV2mRNA形成双重体来抑制EndMT,使其稳定,并增加NAV2蛋白水平.
- NAV2-AS2增强了NAV2与牛的相互作用,导致牛蛋白降低调节和抑制EndMT.
结论:
- NAV2-AS2作为EndMT的新型抑制剂,并具有抗动脉样硬化性质.
- NAV2-AS2/NAV2/Snail轴是调节动脉样硬化中的EndMT的关键通路.
- NAV2-AS2代表了动脉样硬化和相关心血管疾病的潜在治疗标.
相关概念视频
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Types of RNA
6.5K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
6.5K
siRNA - Small Interfering RNAs
17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
MicroRNAs
21.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.8K
Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
RNA Interference
26.5K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.5K


